Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29756827 | 1.00 | MAOA (0.35) | MAOAMAOBKDM4EALDH1A1MEN1 | |
| Methane SCHEMBL5508429 | 0.98 | MAOA (0.34) | MAOAMAOBKDM4EALDH1A1MEN1 | |
| Succinic Acid SCHEMBL7699826 | 0.86 | HTT (0.41) | KDM4EALDH1A1HPGD | |
| SCHEMBL11556600 | 0.86 | MAOA (0.32) | MAOAMAOBKDM4EALDH1A1MEN1 | |
| SCHEMBL4393423 | 0.82 | MAOA (0.33) | MAOAMAOB | |
| SCHEMBL6238159 | 0.78 | HTR2C (0.34) | KDM4EALDH1A1HPGDHTR2CHTR2B | |
| SCHEMBL30407118 | 0.77 | KDM4E (0.35) | KDM4EALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL6337417 | 0.76 | POLB (0.46) | MAOAMAOBMAPT | |
| SCHEMBL293045 | 0.76 | KDM4E (0.37) | KDM4EALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL30096256 | 0.76 | KDM4E (0.38) | KDM4EALDH1A1MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113735363-A | Treatment method of chrome tanning waste liquid | 嘉兴学院 | 2021-12-03 | — | — | CN | claimed |
| EP-3381904-B1 | NOVEL NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND | MITSUBISHI TANABE PHARMA CORP (JP) | 2021-07-28 | — | — | EP | claimed |
| CN-112206350-A | Pretreatment method of bovine pericardial tissue for manufacturing biological valve | 张飞 | 2021-01-12 | — | — | CN | claimed |
| US-10268117-B2 | Top-layer membrane formation composition and method for forming resist pattern using same | AZ ELECTRONIC MATERIALS (LUXEMBOURG) S.A.R.L. (LU) | 2019-04-23 | — | — | US | claimed |
| US-20170090288-A1 | TOP-LAYER MEMBRANE FORMATION COMPOSITION AND METHOD FOR FORMING RESIST PATTERN USING SAME | AZ ELECTRONIC MATERIALS S.À R.L. (LU) | 2017-03-30 | — | — | US | claimed |
| EP-1182183-B1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES MADE BY USING THE SAME | IDEMITSU KOSAN CO (JP) | 2009-12-09 | — | — | EP | claimed |
| US-6605667-B1 | 1,1-disubstituted ethylene monomers such as alpha-cyano-acrylates; storage stability | CLOSURE MEDICAL CORPORATION | 2003-08-12 | — | — | US | claimed |
| WO-2002020069-A2 | ANTIOXIDANT ENRICHED ADHESIVE COMPOSITIONS AND STORAGE CONTAINERS THEREFOR | CLOSURE MEDICAL CORPORATION (US) | 2002-03-14 | — | — | WO | claimed |
| EP-0443533-B1 | Positive photoresist composition | FUJI PHOTO FILM CO LTD (JP) | 1998-09-30 | — | — | EP | claimed |
| EP-0485173-A2 | Esters and amides of substituted fused ring phenyl acetic acids | FGN, INC. (US) | 1992-05-13 | — | — | EP | claimed |
| EP-0443533-A2 | Positive photoresist composition | FUJI PHOTO FILM CO., LTD. (JP) | 1991-08-28 | — | — | EP | claimed |
| US-20250127694-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | COTY INC. | 2025-04-24 | — | — | US | disclosed |
| CN-118290462-A | Dual-channel simultaneous detection pH and ONOO-Fluorescent probe of (2), preparation method and application thereof | 中国科学院理化技术研究所 | 2024-07-05 | — | — | CN | disclosed |
| US-20240197814-A1 | MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES | OAK CREST INSTITUTE OF SCIENCE | 2024-06-20 | — | — | US | disclosed |
| EP-4308146-A1 | MATERIALS AND METHODS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES | Oak Crest Institute of Science (US) | 2024-01-24 | — | — | EP | disclosed |
| EP-0021676-B1 | 3-METHOXY-2-OXOAZETIDINE DERIVATIVES AND THEIR PRODUCTION | Takeda Chemical Industries, Ltd. (JP) | 1983-09-14 | — | — | EP | disclosed |
| US-4108871-A | Novel benzopyran derivatives | SCHERING AKTIENGESELLSCHAFT (DE) | 1978-08-22 | — | — | US | disclosed |
| US-4049653-A | ANALGESICS, ANTIANXIETY AGENTS | ABBOTT LABORATORIES (US) | 1977-09-20 | — | — | US | disclosed |
| US-4032540-A | BENZOPYRAN DERIVATIVES | SCHERING AKTIENGESELLSCHAFT (DT) | 1977-06-28 | — | — | US | disclosed |
| US-3962280-A | PROCESS FOR PREPARING BENZOPYRAN DERIVATIVES | SCHERING AKTIENGESELLSCHAFT (DT) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250127694-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | TRPA1, TRPV1, NAA40 | MAOA 1576/4885MAOB 2868/4885KDM4E 681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.